Subcutaneous immunoglobulin in primary immunodeficiency – impact of training and infusion characteristics on patient-reported outcomes

BACKGROUND: Subcutaneous immunoglobulin (SCIG) is increasingly utilized in primary immunodeficiency (PI). Understanding factors associated with treatment experience and satisfaction can optimize patient outcomes. We analyzed Immune Deficiency Foundation (IDF) survey data to evaluate patient-reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallick, R., Henderson, T., Lahue, B. J., Kafal, A., Bassett, P., Scalchunes, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418302/
https://www.ncbi.nlm.nih.gov/pubmed/32778048
http://dx.doi.org/10.1186/s12865-020-00371-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418302/
https://www.ncbi.nlm.nih.gov/pubmed/32778048
http://dx.doi.org/10.1186/s12865-020-00371-y

Ejemplares similares